Header

UZH-Logo

Maintenance Infos

Correction: Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS


Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Statistics

Citations

Altmetrics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Clinic for Oncology and Hematology
Dewey Decimal Classification:610 Medicine & health
Scopus Subject Areas:Health Sciences > Hematology
Health Sciences > Oncology
Life Sciences > Cancer Research
Language:English
Date:October 2020
Deposited On:19 Oct 2020 16:59
Last Modified:22 Oct 2020 06:20
Publisher:Nature Publishing Group
ISSN:0887-6924
OA Status:Closed
Free access at:Publisher DOI. An embargo period may apply.
Publisher DOI:https://doi.org/10.1038/s41375-020-0994-7
PubMed ID:32733013

Download

Full text not available from this repository.
View at publisher

Get full-text in a library